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Abstract
Streptococcus pneumoniae is an important global pathogen that causes bacterial pneumonia, sepsis and meningitis. Beta- 
lactam antibiotics are the first- line treatment for pneumococcal disease, however, their effectiveness is hampered by beta- 
lactam resistance facilitated by horizontal genetic transfer (HGT) with closely related species. Although interspecies HGT is 
known to occur among the species of the genus Streptococcus, the rates and effects of HGT between Streptococcus pneumoniae 
and its close relatives involving the penicillin binding protein (pbp) genes remain poorly understood. Here we applied the fast-
GEAR tool to investigate interspecies HGT in pbp genes using a global collection of whole- genome sequences of Streptococcus 
mitis, Streptococcus oralis and S. pneumoniae. With these data, we established that pneumococcal serotypes 6A, 13, 14, 16F, 19A, 
19F, 23F and 35B were the highest- ranking serotypes with acquired pbp fragments. S. mitis was a more frequent pneumococ-
cal donor of pbp fragments and a source of higher pbp nucleotide diversity when compared with S. oralis. Pneumococci that 
acquired pbp fragments were associated with a higher minimum inhibitory concentration (MIC) for penicillin compared with 
pneumococci without acquired fragments. Together these data indicate that S. mitis contributes to reduced β-lactam suscepti-
bility among commonly carried pneumococcal serotypes that are associated with long carriage duration and high recombina-
tion frequencies. As pneumococcal vaccine programmes mature, placing increasing pressure on the pneumococcal population 
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DATA SUMMARY
Streptococcus pneumoniae genome sequences used in this 
project are listed in File S1 available in the online version of 
this article and can be accessed under BioProjects PRJEB2417, 
PRJEB2632, PRJEB3084 and PRJEB2357. Accession numbers 
for all publicly available S. mitis and S. oralis genome 
sequences are also listed in File S1 and additional genome 
sequences used in this project can be accessed under BioPro-
jects PRJNA480039, PRJEB42564 and PRJEB42963.
INTRODUCTION
Streptococcus pneumoniae is a common nasopharyngeal 
commensal particularly among children and HIV- affected 
adult populations in sub- Saharan Africa (sSA) [1, 2]. Globally, 
the pathogen is estimated to be responsible for over 318 000 
deaths annually among children less than 5 years of age due to 
bacteraemic pneumonia, sepsis and meningitis [1, 3]. Pneu-
mococcal serotypes associated with invasive pneumococcal 
disease (IPD) and antibiotic resistance have been targeted by 
pneumococcal conjugate vaccines (PCVs) [4, 5] and their 
rollout has led to a reduction of vaccine serotype (VT) IPD 
and pneumococcal antimicrobial resistance [6, 7]. However, 
the pneumococcus has been able to escape these interven-
tions, leading to the expansion of resistant non- vaccine 
serotypes (NVTs) [8, 9], residual carriage of VTs [10, 11] and 
serotype switching [12–15].
Antibiotic resistant pneumococcal lineages that continue to 
evade vaccine interventions are of considerable public health 
concern [16]. In the United States the post- PCV introduction 
era has seen the expansion of serotype 35B sequence type 
(ST) 558 [17], a resistant NVT lineage that has been associ-
ated with IPD in the region, as well as a 35B switch variant 
that has recently emerged [8, 17, 18]. In high disease burden 
regions, immunised children continue to carry antibiotic 
resistant VTs, which include serotypes 19A and 19F, despite 
good vaccine coverage [11, 19–21]. Additionally, multidrug- 
resistant (MDR) S. pneumoniae clones defined by the Pneu-
mococcal Molecular Epidemiology Network (PMEN) [22], 
such as Sweden15A-25/ST63 and Netherlands15B-37/ST199, 
spreading globally continue to remain important causes of 
invasive disease in the post- PCV13 era [23–25].
Beta- lactam (β-lactam) antibiotics, including penicillin, are 
the first line treatment for pneumococcal disease, however, 
the emergence of β-lactam resistance presents a global threat 
[26]. The mechanism of pneumococcal β-lactam resistance 
involves alterations in the transpeptidase domains (TPDs) 
located within the penicillin- binding protein (pbp) genes, 
namely pbp1a, pbp2b and pbp2x [27–29]. Results from several 
genomic studies have indicated that the pbp genes (pbp1a, 
pbp2b, pbp2x) within the pneumococcal genome are hotspots 
for intraspecies recombination events [13, 30]. Nucleotide 
sequencing studies in the early 1990s provided the first 
evidence of interspecies genetic transfer between the pneu-
mococcus and Streptococcus mitis [31–43]. More recently, 
the application of methods for detecting horizontal genetic 
transfer (HGT) [44, 45] have provided further evidence for 
the emergence of β-lactam resistance in the pneumococcus 
facilitated by HGT with closely related commensal strepto-
cocci such as S. mitis and Streptococcus oralis [46–48]. These 
species are predominant in the oropharynx [49, 50] and are 
of less pathogenic potential than the pneumococcus, however, 
they are widely regarded as reservoirs for antibiotic resistance 
determinants for the pneumococcus.
Although interspecies HGT at pbp gene loci is known to occur 
among the species of the genus Streptococcus [31–42, 48], the 
rates and effects of HGT at pbp genes between closely related 
non- pneumococcal streptococci and individual pneumo-
coccal carriage serotypes, genotypes and sequence types is 
uncertain. We propose the hypothesis that pneumococcal 
serotypes that frequently colonise the human nasopharynx 
for long durations and have higher proportions of observed 
recombination, are the predominant recipients of pbp gene 
fragments from commensal streptococci, resulting in reduced 
pneumococcal penicillin susceptibility.
To detail the evolution of pneumococcal β-lactam resistance 
among lineages that continue to evade vaccine intervention, 
we have therefore investigated HGT at pbp, housekeeping 
and other antimicrobial resistance (AMR) genes among S. 
mitis, S. oralis and pneumococcal strains obtained through 
pneumococcal disease surveillance programmes and carriage 
studies including the Global Pneumococcal Sequencing 
(GPS) project [51]. Our study highlights S. mitis as a more 
Impact Statement
Streptococcus pneumoniae, also known as the pneumo-
coccus, is a global pathogen that is regarded as a serious 
antimicrobial resistance threat. The transfer of genetic 
material from Streptococcus mitis to the pneumococcus at 
genes that confer resistance to penicillin has contributed 
to pneumococcal antimicrobial resistance. However, the 
effect of genetic transfer between S. mitis and different 
S. pneumoniae serotypes at the penicillin genes is uncer-
tain. We applied genetic transfer inference software to 
investigate genetic transfer within the penicillin genes 
using 1000 strains of S. pneumoniae from global carriage 
studies, and a comprehensive dataset of publicly avail-
able S. mitis and S. oralis whole genome sequences. We 
identified recent genetic transfer at the penicillin genes 
mostly from S. mitis to S. pneumoniae, and S. pneumoniae 
serotypes associated with long carriage duration in the 
human upper respiratory tract were the main recipients. 
S. pneumoniae strains with acquired genetic material 
were also associated with reduced susceptibility to peni-
cillin. The findings will serve as a foundation for moni-
toring genetic transfer of antimicrobial resistance in the 
pneumococcus, particularly in regions where the pneu-
mococcus is under increasing pressure from antibiotic 
use and pneumococcal conjugate vaccine uptake.
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frequent donor of genetically diverse pbp gene fragments to 
S. pneumoniae compared with S. oralis. The horizontal acqui-
sition of the pbp fragments mostly occurs among pneumo-
coccal serotypes associated with prolonged nasopharyngeal 




All publicly available Streptococcus mitis and Streptococcus 
oralis genome assemblies were downloaded from the NCBI 
database and were from both carriage and invasive disease. 
The source was unknown for some of the strains (See File S1 
for a list of accession numbers and origins). Additional S. mitis 
(n=31) and S. oralis (n=23) genome assemblies from naso-
pharyngeal carriage were obtained from MRC The Gambia 
(Banjul, Gambia), and whole genome sequencing and species 
identification was done at the University of Leicester (File S1). 
S. mitis genome assemblies from University College London 
(n=4) and the US Centres for Disease Control and Prevention 
(CDC; n=5) obtained from carriage were also included in the 
analysis (File S1). In total we obtained 174 S. mitis and 135 S. 
oralis genomes for species confirmation. It should be noted 
that very few non- pneumococcal streptococci have been 
sequenced in comparison to the pneumococcus, therefore, 
the undersampled S. mitis and S. oralis datasets are a limita-
tion in investigating the extent of interspecies HGT.
To obtain adequate coverage of global pneumococcal carriage 
serotypes, pneumococcal carriage datasets from the Global 
Pneumococcal Sequencing (GPS) Project (http://www. pneu-
mogen. net/ gps/) were used to sample S. pneumoniae genome 
assemblies (n=1000) (File S1). Pneumococcal carriage datasets 
from Malawi, Gambia, Thailand, the UK and the USA were 
selected to obtain representation across different continents, 
and 200 genomes were randomly selected from each dataset.
Analysis platforms and genomic analysis
Internal automated pipelines and computing clusters devel-
oped and maintained by the Wellcome Sanger Institute (WSI; 
Hinxton, Cambridgeshire, UK) were used for whole genome 
sequence analysis, where the genomic data was all analysed 
at the same time [51, 52]. Additional genomic analyses were 
carried out at UCL and through the genomic surveillance 
PathogenWatch application (https:// pathogen. watch/).
Taxonomic classification of S. pneumoniae, S. mitis and S. 
oralis genome assemblies was done using KRAKEN v1.0 [53] 
to confirm species identity. Genome quality was determined 
using the quality assessment tool for genome assemblies 
(QUAST v5.0.2) [54]. Genomes that were not assigned as S. 
pneumoniae, S. mitis and S. oralis were excluded from the 
analysis. The streptococcal genome assemblies were then 
annotated using Prokka v1.13.4 [55] as part of the WSI anno-
tation pipeline, and pangenome analysis was conducted using 
Roary v3.13.0 [56] in the WSI pangenome pipeline to obtain 
core genome alignments. Pangenome analysis was run for 
the three streptococcal species together and separately for the 
pneumococcal strains to obtain two core genome alignments. 
Capsular serotyping and sequence typing based on the pneu-
mococcal multilocus sequence typing scheme (MLST) were 
conducted using SeroBA v1.0.1 [57] and BIGsdb [58] respec-
tively, while determination of newly proposed nomenclature 
by the GPS project of Global Pneumococcal Sequence Clus-
ters (GPSCs) for internationally distributed pneumococcal 
lineages [59] was done using the PathogenWatch application 
(https:// pathogen. watch/).
Phylogenetic analysis
Multiple sequence alignments of polymorphic nucleotide sites 
were generated from the core genome alignments inferred 
by Roary pangenome analysis pipeline using snp- sites v2.5.1 
[60]. The alignment of polymorphic sites was then used to 
reconstruct maximum- likelihood phylogenies using fasttree 
v2.1.10 [61]. We used the generalized time- reversible model 
of nucleotide evolution to generate the phylogenies, which 
were visualized and annotated using the online Interactive 
Tree of Life (iToL) software v3.0 [62] and microreact v5.93.0 
[63]. Nucleotide- blast v2.10.1 [64] was used to extract pbp1a, 
pbp2b and pbp2x gene sequences. The pbp sequences were 
then aligned using muscle v3.8.1551 within the Molecular 
Evolutionary Genetics Analysis (mega) software v10.0 [65]. 
Population clustering of the pbp gene sequences was inferred 
using Bayesian Analysis of Population Structure (BAPS) 
[66] implemented via the fastGEAR tool [67]. Phylogenetic 
trees based on the pbp gene alignments were similarly recon-
structed and visualised using the methods and parameters 
described above.
Nucleotide sequence polymorphism and pbp 
binding motif analysis
The analysis of polymorphisms in pbp1a, pbp2b and pbp2x 
nucleotide sequences was conducted for S. pneumoniae, S. 
mitis and S. oralis using DnaSP v6 [68] to estimate the number 
of segregating sites (S), nucleotide diversity (π) and average 
number of pair- wise nucleotide differences within a popula-
tion (K). We used a sliding window of 100 bases with a step 
size of 25 bp to calculate the nucleotide diversity of pbp genes 
from each species, and the respective plots were generated 
using the package ggplot2 [69] in R v3.6.3 [70]. Amino acid 
residues in the TPDs of pbp1a, pbp2b and pbp2x active binding 
motifs were analysed for each species using mega v10.0 
and compared with the motifs of the β-lactam susceptible 
S. pneumoniae R6 (GenBank Accession GCA000007045.1). 
The domain regions used for the analysis were 370STMK373, 
428SRNVP432, 574KTG576 for pbp1a, 391SVVK394, 448SSNT451 and 
620KTGTA624 for pbp2b and 337STMK340, 393AHSSNV398 and 
546LKSGT550 for pbp2x [71].
Pneumococcal genotypic resistance
Pneumococcal β-lactam minimum inhibitory concentrations 
(MIC) were genotypically predicted using an analysis pipeline 
developed by the CDC [72, 73], and the results are reported 
in File S1. The MICs were interpreted using the Clinical and 
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Laboratory Standards Institute (CLSI) guidelines and clinical 
breakpoints (https:// clsi. org/). Genotypically predicted 
β-lactam resistance profiles and MICs using the pipeline are 
highly accurate and have been previously validated among 
some strains with available phenotypic data using CLSI 
breakpoints [72–75], and the pipeline has also been applied 
to pneumococcal isolates from the GPS Project [51, 52, 76].
Horizontal genetic transfer analysis
The fastGEAR horizontal genetic transfer (HGT) software 
[44] was used to estimate and plot the amount of recent 
HGT in the pbp genes of S. pneumoniae, S. mitis and S. oralis. 
The sequence clusters of the pbp1a, pbp2b and pbp2x gene 
sequences were inferred using BAPS [66] within fastGEAR. 
The pbp sequence clusters inferred by BAPS that shared a 
common ancestry in at least 50 % of the sites were collapsed 
into recombination lineages using a hidden Markov model 
(HMM) [44]. The fastGEAR tool then detected recent recom-
bination events between pbp recombination lineages using an 
HMM, and the origin of the recombinant sequence was then 
assigned to the pbp recombination lineage with the highest 
probability at that position. The statistical significance of 
recombination predictions was tested using a Bayes factor 
(BF) >1 for recent recombination events. The HGT analyses 
of pbp1a, pbp2b and pbp2x gene alignments were conducted 
individually using the default settings in fastGEAR. The HGT 
patterns between pbp lineages were visualised using ggplot2 
[69] in R [70] and Cystoscape v 3.8.0 [77]. As an internal 
check of the pbp HGT analysis, we also investigated the extent 
of genetic transfer occurring at other streptococcal genes as 
a comparison. We investigated HGT among seven pneumo-
coccal multi- locus sequence typing genes [78, 79], namely; 
shikimate dehydrogenase (aroE), d- alanine–d- alanine ligase 
(ddl), glucose-6- phosphate dehydrogenase (gdh), glucose 
kinase (gki), transketolase (recP), signal peptidase I (spi) and 
xanthine phosphoribosyltransferase (xpt). We also compared 
HGT among six other antibiotic resistance related genes, 
namely; dihydrofolate reductase (folA), dihydropteroate 
synthase (folP), DNA gyrase subunit A (gyrA), DNA gyrase 
subunit B (gyrB), DNA topoisomerase 4 subunit A (parC) and 
DNA topoisomerase 4 subunit B (parE).
Statistical analyses
Mosaicism among the pbp genes, β-lactam susceptibility 
and active binding site motif status was compared among 
the pneumococci using the two- tailed Fisher’s exact test in 
GraphPad Prism v8.0 (GraphPad Software). The distribution 
of acquired pbp fragment sizes and the β-lactam MICs for 
pneumococcal strains with and without pbp mosaicism were 
assessed using the Mann–Whitney test. A P- value of less than 
0.05 was considered to be statistically significant.
RESULTS
Genomic identification of Streptococci
Following initial assessment of the quality and species assign-
ment using KRAKEN v1.0 [53], we confirmed that 81 % (141 
out of 174), 93 % (125 out of 135) and 100 % (1000 out of 
1000), of S. mitis, S. oralis and S. pneumoniae respectively 
had been correctly identified (File S1). Two percent (3 out of 
135) of S. oralis were reassigned as S. mitis, and 6 % (11 out of 
174) of S. mitis were reassigned as S. oralis. We excluded one S. 
oralis and four S. mitis genomes among the confirmed species 
due to their having partial pbp genes from poorly assembled 
gene regions. In total, we used 1000 S. pneumoniae, 140 S. 
mitis and 135 S. oralis genomes in the HGT analysis.
Population structure of global pneumococcal 
isolates
To establish the genetic diversity of the randomly sampled 
pneumococcal genomes, we characterised the strains through 
in- silico serotyping, sequence typing, lineage inference based 
on the GPSC nomenclature and prediction of β-lactam 
susceptibility. The core genome maximum likelihood phylo-
genetic tree of the pneumococcal isolates indicated that the 
pneumococcal isolates clustered in 176 GPSCs Fig. 1a. The 
random selection of 1000 pneumococcal genomes covered 
dominant, intermediate and rare GPSCs. Greater genomic 
diversity was observed among the 140 publicly- available S. 
mitis genomes (Fig. 1b), as previously described for a more 
limited dataset [80, 81].
We identified a total of 61 serotypes and 391 sequence types 
(STs) among the 1000 pneumococcal isolates (File S1). Pneu-
mococcal conjugate vaccine 13 (PCV13) vaccine types (VTs) 
accounted for 43.9 % (439 out of 1000) of the isolates, which 
were spread across 81 GPSCs. A total of 36.7 % (161 out of 
439) penicillin non- susceptible VT isolates with a penicillin 
MIC of greater than 0.06 µg ml−1 were identified (Table S1). 
We observed a high frequency of penicillin nonsusceptibility 
for serotypes 6A (19 out of 74), 6B (16 out of 56), 14 (27 
out of 34), 19A (28 out of 52), 19F (32 out of 52) and 23F 
(31 out of 64) compared with other VTs (Table S2). PCV13 
non- vaccine serotypes (NVTs) accounted for 51.0 % (510 out 
of 1000) of the isolates and were spread across 104 GPSCs, 
and 14.3 % (73 out of 510) were penicillin non- susceptible. 
Compared with other NVTs, we observed a high frequency 
of penicillin non- susceptibility among serotypes 13 (9 out of 
15), 15A (13 out of 34), 34 (9 out of 27),and 35B (22 out of 
36). Non- typeable pneumococci accounted for 5.1 % (51 out 
of 1000) of the isolates analysed and were spread across 17 
GPSCs.
S. mitis and S. oralis are reservoirs of altered pbp 
active binding site motifs and pbp genetic diversity
We investigated the pbp active binding site motifs in the 
TPD regions to identify species that are potential reservoirs 
of binding motif residues associated with pneumococcal 
β-lactam non- susceptibility. While the pbp binding site motif 
variants identified in S. pneumoniae confer reduced pneu-
mococcal β-lactam susceptibility [28, 82–84], it has not been 
determined whether they confer reduced β-lactam suscep-
tibility in S. oralis and S. mitis. Nonetheless, by comparing 
the active binding site motifs of the streptococcal genomes 
to motifs of the β-lactam- susceptible S. pneumoniae R6 
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Fig. 1. Core genome maximum likelihood phylogenies and transpeptidase active binding site analysis of S. pneumoniae, S. mitis and S. 
oralis. a) The maximum likelihood phylogeny of 1000 randomly selected carried pneumococcal strains from the Global Pneumococcal 
Sequencing Project datasets were constructed using core genome SNPs. The phylogeny demonstrates genetic similarity and diversity 
among the isolates. The strain metadata, namely GPSC, serotype, PCV13 status and β-lactam antibiotic susceptibility are shown. Support 
at the branches is indicated by the bootstrap values, and the tree was rooted at the mid- point. b) Core genome maximum likelihood 
phylogeny and active binding domain analysis of S. pneumoniae, S. mitis and S. oralis penicillin- binding proteins. On the left is a maximum 
likelihood tree based on core genome SNPs of S. pneumoniae (red), S. mitis (green) and S. oralis (blue). Pneumococcal strain metadata, 
namely GPSC, serotype, PCV13 status and β-lactam antibiotic susceptibility are shown. The larger panel on the right corresponds to 
the strains in the core genome phylogeny and shows the changes in pbp1a, pbp2b and pbp2x amino acid residues compared with the 
conserved pbp binding motifs of the β-lactam- susceptible S. pneumoniae R6 reference.
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genome (GenBank Accession GCA000007045.1), we identi-
fied amino acid changes in seven out of nine binding motifs 
among the streptococci (Fig. 1b). The domain regions used 
for the analysis were 370STMK373, 428SRNVP432, 574KTG576 for 
pbp1a, 391SVVK394, 448SSNT451 and 620KTGTA624 for pbp2b and 
337STMK340, 393AHSSNV398 and 546LKSGT550 for pbp2x [85]. 
Overall, the majority of S. pneumoniae (699 out of 1000) had 
conserved pbp active binding motifs, whilst the vast majority 
of S. mitis (120 out of 140) and S. oralis (132 out of 135) had 
active binding motifs that are altered in the pneumococcus 
(Tables S3 and S4).
To demonstrate the relationship between pbp active binding 
motif status and β-lactam susceptibility in our global pneu-
mococcal dataset [28, 82–84], we investigated the prevalence 
of altered pbp TPD residues among β-lactam susceptible and 
nonsusceptible pneumococci (Table S5). Among the 732 
penicillin susceptible streptococcus pneumococci (PSSP), 
91.1 % (667 out of 732) had conserved motifs and 8.9 % (65 
out of 732) had altered motifs. While among the penicillin 
non- susceptible streptococcus pneumococci (PNSP), 11.4 % 
(30 out of 264) had conserved motifs and 88.6 % (234 out 
of 264) had altered motifs. There was a strong association 
between pbp motif status and penicillin susceptibility among 
the pneumococcal isolates (Fisher’s exact test P<0.0001).
We then explored pbp nucleotide diversity to quantify the 
amount of pbp gene variation among the different strepto-
coccal species (File S1). S. mitis had the highest number of 
average nucleotide differences (K) for pbp1a (266.438), pbp2b 
(272.779) and pbp2x (207.083). Whilst S. pneumoniae had 
the least number of nucleotide differences for pbp1a (81.369), 
pbp2b (57.773) and pbp2x (86.710). A sliding window plot of 
nucleotide diversity (π) revealed that the streptococcal species 
have different patterns of nucleotide diversity throughout 
their sequences, but confirmed that S. mitis has a greater 
nucleotide diversity compared with S. pneumoniae and S. 
oralis across all pbp genes (Fig. 2).
Extensive mosaicism occurs among the 
streptococcal pbp genes
We then aimed to determine the role that S. mitis plays as 
a pneumococcal genetic exchange partner for the pneumo-
coccus compared with S. oralis and other pneumococci. We 
therefore investigated intraspecies and interspecies HGT of 
pbp gene fragments among S. pneumoniae, S. mitis and S. 
oralis using fastGEAR. We identified mosaicism among 36 % 
(361 out of 1000) of S. pneumoniae, 94 % (131 out of 140) of S. 
mitis and 79 % (106 out of 135) of S. oralis (Table 1) using the 
extracted and aligned pbp1a (1737 bp), pbp2b (2049 bp) and 
pbp2x (1686 bp) sequence alignments. S. mitis and S. oralis 
had a higher proportion of strains with recombined pbp1a, 
pbp2b and pbp2x genes compared with the pneumococcus. 
However, the undersampled non- pneumococcal species data-
sets do not provide a robust statistical signal to find potential 
recent HGT events into S. mitis or S. oralis. In relation to the 
previously described transpeptidase binding motif analysis 
(Fig. 1b), among the pneumococci with acquired pbp frag-
ments 79.8 % (288 out of 361) strains had altered motifs and 
20.2 % (73 out of 361) strains had conserved motifs. Whilst 
among the pneumococci that did not acquire pbp fragments, 
2.0 % (13 out of 639) strains had altered motifs and 98.0 % (626 
out of 639) of strains had conserved motifs. There was a strong 
association between pbp recombination and binding motif 
status among the pneumococci (Fisher’s exact test P<0.0001).
To better understand streptococcal HGT at the level of pbp 
gene clusters, we investigated HGT among the pbp genes using 
maximum- likelihood phylogenies [48]. Phylogenetic analysis 
of the pbp genes revealed the sequences largely clustered by 
species (Fig.  3a–c I). S. mitis and S. oralis pbp sequences 
formed clusters with multiple deep branching lineages, whilst 
Fig. 2. Nucleotide diversity sliding window analysis of S. pneumoniae, S. mitis and S. oralis penicillin- binding protein genes. The nucleotide 
analysis was applied to S. pneumoniae, S. mitis and S. oralis pbp1a (1737 bp), pbp2b (2049 bp) and pbp2x (1686 bp) alignments. Sliding 
window plot analysis showing nucleotide diversity (π) values across pbp sequences analysed for S. pneumoniae, S. mitis and S. oralis. 
A window size of 100 bp and a step size of 25 bp was used. The transpeptidase binding domain regions that harbour the active binding 
site motifs are highlighted.
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the majority of S. pneumoniae sequences were highly similar, 
less diverse and clustered together. The pbp genetic clusters 
identified using BAPS analysis supported the genetic clusters 
shown among the pbp phylogenies (Fig. 3a–c III). S. pneumo-
niae, S. oralis and S. mitis pbp sequences generally grouped 
together in several species- distinct pbp BAPS clusters. 
However, mixed species pbp sequences that clustered together 
by phylogeny were mostly observed between S. mitis and S. 
pneumoniae, indicating HGT. To infer recent HGT, pbp BAPS 
clusters that shared a common ancestry in at least 50 % of 
the sites were collapsed into pbp recombination lineages [44]. 
S. pneumoniae pbp1a sequences largely clustered together in 
a highly conserved recombination lineage 17 (Fig. 3a IV), 
but we identified evidence of HGT of pbp1A fragments from 
S. mitis (recombination lineage 7 and 11 origin) (Fig.  3a 
IV) and S. oralis (recombination lineage 16 origin) among 
pneumococcal strains in lineage 17. There is clear evidence of 
HGT of pbp fragments from S. mitis to S. pneumoniae that is 
consistent with reults reported previously [48]. Similarly, we 
also observed pbp fragment acquisition among pneumococcal 
recombination lineages for pbp2b (recombination lineages 
8 and 10) and pbp2x (recombination lineages 8, 11 and 12). 
Acquired fragments predominately originated from S. mitis 
and other strains of S. pneumoniae (Fig. 3b, c IV). However, 
the undersampled non- pneumococcal genome datasets are 
a limitation and do not provide a robust statistical signal to 
accurately assess the extent and bi- directional HGT among 
the species.
We then quantified the amount of HGT between the pbp 
recombination lineages to determine the extent to which 
each streptococcal species acted as a recombination donor 
(Fig. 4a–c). While the undersampled non- pneumococcal 
datasets remain a main limitation in assessing interspecies 
HGT, the results of this analysis indicate the proportion 
of pbp sequence variation originating from the source to 
strains assigned to the target lineage using a comprehensive 
dataset of publicly available S. mitis and S. oralis genomes. 
Similar to Fig.  3, pneumococcal pbp sequences mostly 
occupied pbp1a lineage 17 (Fig. 4a), pbp2b lineage 8 and 10 
(Fig. 4b) and pbp2x gene lineage 8, 11 and 12 (Fig. 4c) in 
the admixture analysis of recent HGT. S. mitis was a greater 
source of pbp variation for the dominant pneumococcal pbp 
recombination lineages compared with S. oralis, however, 
we also observed intraspecies HGT among pneumococcal 
pbp lineages.
Pneumococcal serotypes and genotypes with a high 
proportion of acquired pbp fragments
We investigated the acquisition of pbp fragments in the 
context of pneumococcal VTs, NVTs, GPSCs and STs to 
identify pneumococci with greater interspecies acquisition 
of HGT fragments. Fig. 5a, b summarise the number and 
donor origins of fragments acquired by VTs and NVTs 
respectively, where 46.9 % (206 out of 439) of VTs and 
22.4 % (114 out of 510) of NVTs acquired pbp fragments 
in at least one pbp gene. Among the non- typable pneumo-
cocci, 80.4 % (41 out of 51) had acquired fragments in at 
least one pbp gene. A high proportion of VTs with acquired 
pbp fragments included serotypes 6A (38 out of 74), 14 (30 
out of 34), 19A (30 out of 52), 19F (35 out of 52) and 23F 
(39 out of 64) (Table S6), which were spread across various 
GPSCs (Table S7). NVTs with a high proportion of strains 
with acquired pbp fragments included serotypes 13 (9 out 
of 15), 16F (14 out of 29) and 35B (23 out of 36). Whilst 
non- typeable strains (41 out of 51) that received pbp frag-
ments were from multiple GPSCs. Among the multiple STs, 
all 30 penicillin non- susceptible ST63 strains (Serotype 14) 
had acquired pbp fragments mostly from S. mitis and S. 
pneumoniae (Table S8). Serotype 35B ST558 strains (12 out 
of 13) were also among the top ranking STs with acquired 
pbp fragments from predominantly S. mitis and other S. 
pneumoniae strains (Table S8).
We established the donor sources of all acquired pbp frag-
ments among each species, and the predominant donors 
for S. pneumoniae were S. mitis and other S. pneumoniae 
(Fig. 5c). Among the acquired pbp fragments we identi-
fied among the pneumococci, 125 (41.5 %), 187 (43.0 %) 
and 412 (53.9 %) of the respective pbp1a, pbp2b and pbp2x 
fragments were of S. mitis origin. Whilst 119 (39.5 %), 223 
(51.3 %) and 277 (36.2 %) of the respective pbp1a, pbp2b and 
pbp2x fragments were from other strains of S. pneumoniae. 
S. oralis contributed to a much less extent as a donor for S. 
pneumoniae pbp1a (18.9%), pbp2b (4.8%) and pbp2x (0.0%) 
fragments. Mixed species with recombined pbp genes 
were also donors of pbp fragments, therefore for multiple 
acquired fragments the donor species may have been S. 
mitis, S. oralis or S. pneumoniae. We observed a greater 
degree of pbp fragment acquisition in the TPD region of 
pneumococcal pbp genes (83.4–94.4 %), which harbour 
the active binding motifs, compared with regions outside 
the TPD (Fig. S1). These results are consistent with those 
from previous studies [31–43]. We also analysed the sizes 
Table 1. Number and proportion of S. pneumoniae, S. mitis and S. oralis isolates with horizontally acquired pbp gene fragments identified using fastGEAR
Species Number of strains Number and proportion (%) of strains with recombined pbp genes
    pbp1a pbp2b pbp2x Any pbp gene
S. pneumoniae 1000 123 (12) 196 (20) 346 (35) 361 (36)
S. mitis 140 42 (30) 99 (71) 72 (51) 131 (94)
S. oralis 135 60 (44) 65 (48) 52 (39) 106 (79)
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Fig. 3. Horizontal genetic transfer analysis of pbp1a, pbp2b and pbp2x gene fragments among S. pneumoniae, S. mitis and S. oralis 
using the fastGEAR tool. On the left are I) maximum likelihood phylogenies based on a) pbp1a, b) pbp2b c) pbp2x gene alignments of S. 
pneumoniae, S. mitis and S. oralis. II) Species III) Bayesian analysis of population structure (BAPs) clusters of pbp1a, pbp2b and pbp2x 
determined using fastGEAR. IV) Recombination (lineage) block panel with HGT fragments identified by FastGEAR over the length of the 
pbp genes. Blocks of the same colour are proposed to be of the same origin (based on recombination lineages detected by fastGEAR). 
The transpeptidase binding domain regions that harbour the active binding site motifs are shown. The recombination lineages for the 
streptococcal pbp genes are shown next to the recombination lineage block panel.
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of the acquired pbp fragments (Fig. 5d), and the median 
sizes of the acquired fragments for the three species ranged 
from 105 to 133 bp for pbp1a, from 206 to 229 bp for pbp2b 
and from 147 to 182 bp for pbp2x. There was no significant 
difference in the size distribution of pbp fragments acquired 
across pbp1a and pbp2x genes among the species. However, 
we observed a significant difference in the size distribution 
between all species for fragments acquired in the pbp2b 
gene (P<0.0455), with S. pneumoniae having acquired larger 
pbp fragments compared with S. mitis and S. oralis.
We then investigated the acquisition of pbp fragments in 
context of GPSCs, to determine if particular genotypes 
had a greater interspecies acquisition of HGT fragments. 
Fig. 4. Admixture between streptococcal pbp1a, pbp2b and pbp2x fastGEAR lineages based on recent recombinations. Genetic 
interactions are shown between lineages identified by fastGEAR for a) pbp1a, b) pbp2b and c) pbp2x based on recent recombinations. 
Recombination lineages are coloured according to the dominant species within that pbp lineage, and the size is proportional to the 
number of pbp sequences within the lineage. Arrows indicate the proportion of sequence variation originating from the source lineage 
to pbp sequences of strains assigned to the target lineage. The highest proportions of variation originating from source lineages are 
indicated by bold arrows.
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Fig. 5. Analysis of pbp fragments acquired by pneumococcal serotypes, S. mitis and S. oralis strains. Distribution and size of acquired 
pbp fragments, pbp donor sources and β-lactam susceptibility among pneumococcal a) vaccine serotypes b) non- vaccine serotypes. 
Predicted pneumococcal β-lactam resistance is shown in the last columns where the antibiotics are; 1. Penicillin, 2. Amoxicillin, 3. 
Cefuroxime, 4. Cefotaxime, 5. Ceftriaxone. c) Donor source proportions of horizontally acquired pbp fragments among S. pneumoniae, S. 
mitis and S. oralis using recombination lineages determined by fastGEAR. d) Size distribution of acquired fragments in the pbp genes of 
S. pneumoniae, S. mitis and S. oralis.
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Overall, the top ranking GPSCs with acquired pbp frag-
ments by proportion of strains were GPSC10 (16 out of 
16), GPSC59 (16 out of 16), GPSC9 (37 out of 39), GPSC5 
(16 out of 17), GPSC1 (23 out of 27), GPSC20 (22 out of 
23) and GPSC45 (9 out of 15) (Fig. S2). Table S7 shows 
the associated serotypes of the top ranking GPSCs with 
acquired pbp fragments by proportion of strains. A high- 
resolution view of intraspecies and interspecies HGT of 
pbp fragments is summarised in Fig. 6, where evidence of 
S. mitis to S. pneumoniae HGT is illustrated for the top- 
ranking S. pneumoniae GPSCs.
Interspecies pbp HGT occurs among intermediate 
and rare pneumococcal GPSCs
Our original analytical approach was to assess the epidemi-
ological importance of pbp HGT between S. mitis, S. oralis 
and S. pneumoniae genotypes. However, the epidemiological 
sampling approach may have underestimated the potential 
for rarer pneumococcal genotypes to acquire pbp gene frag-
ments. We have therefore used a phylogenetically informed 
approach to obtain previously undersampled intermediate 
and rare sequence clusters (Table S9), maximising genetic 
diversity in the HGT analysis. Using the GPS dataset of 
13 454 strains [86], we randomly selected 1–2 genomes per 
intermediate and rare GPSC, as a majority of rare GPSCs 
(197 out of 371) are represented by one strain each [86]. We 
obtained 809 pneumococcal genomes which represented 
all 132 intermediate and 371 rare GPSCs in total (Table S9) 
and these genomes are listed in File S1. The results of this 
additional analysis indicate that HGT occurs among the pbp 
genes of 82 out of 264 (31 %) intermediate and 134 out of 
545 (25 %) rare GPSC strains (Figs S3–S5) and that there is 
evidence of S. mitis to S. pneumoniae HGT for more than 
50 % of acquired fragments across each pbp gene (Fig. S6). 
The results obtained in this additional analysis are there-
fore similar to those from the epidemiologically sampled 
dataset, specifically that a high proportion serotype 6A, 
6B, 19A, 19F, 23F and non- typeable strains have acquired 
pbp fragments (Fig. S7). However, the phylogenetically 
informed approach highlights that HGT occurs even among 
intermediate and rare genotypes.
Decreased β-lactam susceptibility among 
pneumococci with acquired pbp fragments
We used the epidemiologically sampled pneumococcal 
dataset to determine if there is an association between 
pbp fragment acquisition and β-lactam susceptibility. 
Fig. 7 shows the distribution of β-lactam MIC among the 
pneumococci with and without acquired pbp fragments. 
Pneumococcal isolates which acquired pbp fragments 
(361 out of 1000) had a higher median MIC and wider 
MIC range for penicillin (0.25 µg ml−1, 0.03125–4 µg ml−1), 
compared with pneumococci without acquired fragments 
(0.03 µg ml−1, 0.03125–0.0625 µg ml−1). Similarly, higher 
median MIC values for amoxicillin (0.125 µg ml−1) and 
cefotaxime (0.125 µg ml−1) were observed for pneumo-
cocci which acquired pbp fragments, compared to isolates 
without acquired fragments (amoxicillin - 0.03 µg ml−1, 
cefotaxime - 0.0625 µg ml−1). Pneumococci which acquired 
pbp fragments also had wider MIC ranges for amoxicillin, 
cefuroxime, and ceftriaxone compared with pneumococci 
without acquired fragments.
The mean MICs for penicillin, amoxicillin, cefuroxime, 
cefotaxime and ceftriaxone were significantly different 
(P<0.0001) between pneumococci with and without 
acquired pbp fragments. Pneumococcal isolates which did 
not acquire pbp fragments (639 out of 1000) were fully 
susceptible to penicillin (MIC <0.06 mg ml−1), amoxicillin 
(MIC <0.5 mg ml−1), cefotaxime (MIC <0.5 mg ml−1) and 
ceftriaxone (MIC <0.5 mg ml−1). The results we obtained 
showing the relationship between pbp recombination 
and reduced penicillin susceptibility has previously been 
demonstrated using fastGEAR [44], and the relationship 
between mosaic pbp genes and reduced susceptibility in the 
pneumococcus is also supported by earlier work [31–43].
HGT among MLST house-keeping and other 
antibiotic resistance genes
As an internal check of HGT, we also investigated HGT 
among seven housekeeping genes used for pneumococcal 
MLST (Fig. S8) and six other genes associated with AMR 
(Fig. S9). We applied the internal check on the epidemio-
logically sampled pneumococcal dataset. S. pneumoniae 
had the least proportion of strains with horizontally 
acquired fragments in the MLST genes (0–9 %) compared 
with S. mitis (2.9–20 %) and S. oralis (0–20.1 %) (Table S10). 
Unlike other MLST genes, the ddl gene had pneumococcal 
sequences scattered across the entire phylogeny (Fig. S8b), 
predominately among S. mitis ddl BAPS clusters, indicating 
HGT. Our observation is supported by earlier work that has 
described the pbp2B–ddl gene region as an observed recom-
bination hotspot [40], presumably as a function of selectable 
pbp2B alleles. Among the AMR genes, we observed a 
high degree of mosaicism among S. pneumoniae for folA 
(19.8%) and folP (28.1%) (Table S10), which is consistent 
with previous results [30]. Similarly, we identified a high 
degree of HGT among the folate genes for S. mitis (folA, 
16.4%; folP, 51.4%) and S. oralis (folP, 21.1%). There was 
minimal HGT across genes that confer resistance to fluoro-
quinolone antibiotics for the pneumococcus, with 0–1.9 % 
of pneumococcal isolates having acquired fragments in 
gyrA, gyrB, parC and parE genes. Earlier work similarly 
supports that interspecies recombination contributes mini-
mally to fluoroquinolone resistance in the pneumococcus 
[87]. However, we observed a higher proportion of strains 
with acquired fragments among fluoroquinolone resistance 
genes for S. mitis (5.1–31.4 %) and S. oralis (8.3–46.6 %).
DISCUSSION
We demonstrate extensive HGT among the pbp genes of 
frequently carried pneumococcal serotypes and GPSCs 
associated with long carriage duration, high recombination 
rates and reduced β-lactam susceptibility. Pneumococcal 
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Fig. 6. Genetic interactions among S. pneumoniae, S. mitis and S. oralis pbp genes. Maximum- likelihood trees based on SNPs from the 
core genome alignment of S. pneumoniae, S. mitis and S. oralis are shown in the outermost ring. Connections between donors and 
recipients of pbp fragments based on fastGEAR recombination lineages are shown in the centre for a) pbp1a, b) pbp2b and c) pbp2x, 
where arrows depict recipients of pbp fragments. From the inner ring: Global Pneumococcal Sequence clusters. Next ring: PCV13 status. 
Next five rings: Penicillin, amoxicillin, cefuroxime, cefotaxime and ceftriaxone susceptibility. S. mitis and S. oralis are coloured grey for 
features that included GPSC, PCV13 status and β-lactam susceptibility.
13
Kalizang'oma et al., Microbial Genomics 2021;7:000622
serotypes typically carried for long durations in the human 
respiratory tract [88, 89] that include serotype 6A, 13, 
14, 16F, 19A, 19F, 23F and 35B were the highest ranking 
serotypes with acquired pbp fragments in our analyses. 
S. pneumoniae isolates mostly associated with reduced 
β-lactam susceptibility acquired genetically diverse pbp 
gene fragments predominately from S. mitis, which builds 
upon earlier [31–43] and more recent studies on HGT 
involving pbp genes [48], that provide clear evidence of 
HGT from S. mitis to S. pneumoniae. Together these data 
indicate that the S. mitis are an important reservoir of pbp 
genetic diversity that may facilitate the acquisition of AMR, 
particularly amongst commonly carried pneumococcal 
VTs and NVTs associated with expanding and emerging 
pneumococcal lineages.
HGT between pneumococcal and S. mitis strains is more 
likely to introduce more variation in pneumococcal pbp 
genes that could alter β-lactam susceptibility compared 
with pneumococcal HGT with S. oralis or other strains 
of S. pneumoniae. Our results indicate that S. mitis is an 
important donor of genetically diverse pbp mosaic frag-
ments to pneumococcal strains compared with S. oralis, 
which provides further evidence supporting the role of S. 
mitis as a major genetic exchange partner with the pneumo-
coccus [31–43, 81, 90]. It has been established that S. mitis 
is genetically more diverse when compared with the pneu-
mococcus [80, 81], therefore this may explain the greater 
sequence diversity of the pbp, MLST and other AMR genes 
observed among S. mitis in comparison to the pneumo-
coccus. S. oralis was less of a pneumococcal HGT partner, 
which is supported by existing evidence that shows that S. 
oralis is more distantly related to the pneumococcus than S. 
mitis [80, 81, 90], and recombination events are known to 
decrease exponentially with genetic distance between donor 
and recipient strains [91]. Pneumococcal intraspecies HGT 
was also common in our analysis, and it has been suggested 
that recombination occurs more frequently within than 
between species [92, 93]. However, in our analysis S. mitis 
had the highest nucleotide diversity across all pbp genes 
compared with S. pneumoniae and S. oralis. At the amino 
Fig. 7. Distribution of β-lactam MIC values for pneumococcal strains with and without acquired pbp fragments. Distribution of penicillin, 
amoxicillin, cefuroxime, cefotaxime and ceftriaxone MICs values for pneumococci with and without acquired pbp fragments. The red 
horizontal dotted lines mark CLSI clinical breakpoints for non- meningitis disease, and all pneumococci with MIC values below the line 
are susceptible and pneumococci with MICs above the line are non- susceptible (intermediate or resistant). The thick black horizontal 
line marks the median MIC for each group, and the rectangle shows the range of MIC values.
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acid level, S. mitis also had a majority of pbp motifs that 
are associated with reduced β-lactam susceptibility in the 
pneumococcus. In support of S. mitis as a source of genetic 
variation, the species has been shown to account for most 
of the pbp2x sequence diversity observed among S. pneu-
moniae and other viridans group streptococci [94]. The role 
of selection at the pbp genes that have among the highest 
rates of recombination in S. pneumoniae is a considerable 
challenge that was not addressed in our work. For example, 
alleles associated with resistance could arise by mutation 
or HGT. Alleles associated with resistance could also 
possibly arise from mutations acquired after recent HGT 
has occurred, and these alleles could also then be recently 
acquired by other pneumococci. Therefore, although selec-
tion may play a role in pneumococcal beta- lactam resist-
ance, it may be difficult to untangle selection in the context 
of recombination. Indeed, it has been established that the 
pbp genes are recombination hotspots in the pneumococcus 
[13, 30], and that beta- lactam resistance has been driven by 
recombination at these loci [31–43, 46–48].
As one of the predominant streptococci in the oropharynx 
[49, 50], S. mitis has served as the most important HGT 
partner for commonly carried pneumococcal serotypes, 
which then appear to frequently serve as gene donors them-
selves of selectable non- pneumococcal pbp gene alleles. We 
found that pneumococci with a high proportion of hori-
zontally acquired pbp fragments were among commonly 
carried serotypes including 6A, 13, 14, 16F, 19A, 19F, 23F 
and 35B [10, 11, 95, 96], which have been previously shown 
to be associated with higher rates of penicillin resistance 
compared with other pneumococcal serotypes [11, 97]. 
The serotypes and related GPSCs with a high proportion of 
acquired pbp fragments in our analyses are known to have 
higher proportions of observed recombinant sequences 
[51, 89], which has been linked to long duration of carriage 
[89]. Commonly carried serotypes with long carriage dura-
tion and a higher propensity for genetic exchange could be 
exposed more frequently to S. mitis in the naso- oropharynx, 
where 51–76 % S. mitis carriage prevalence among healthy 
individuals has been described [49, 50]. Longer and more 
frequent exposure between S. mitis and the pneumococcus 
may provide greater opportunity for HGT events between 
the species. We propose that in high burden regions where 
recombination between pneumococcal strains is likely to 
be high [98], co- colonising S. mitis may be an important 
donor of genetic material for the pneumococcus which may 
contribute to antibiotic resistance [12, 99].
HGT between S. mitis and S. pneumoniae may be particu-
larly important in the context of pneumococcal vaccine 
escape, expansion of NVTs and the emergence of pneumo-
coccal AMR. Serotype 35B ST558, an increasing cause of 
IPD in the post- PCV introduction era in the USA [17] was 
a common recipient of pbp fragments in our analysis that 
was resistant to penicillin, amoxicillin, cefuroxime, cefo-
taxime and ceftriaxone. Over the past 20 years in the USA 
the increase in IPD caused by penicillin non- susceptible 
serotype 35B was due to primarily the ST558 lineage, 
which was demonstrated to be a frequent recombination 
donor for other pneumococci [17]. This is an important 
finding in the context of expanding NVT lineages in the 
post- PCV era, as lineages such as ST558 may have a greater 
propensity for HGT with commensal species and other 
pneumococci. Thus, ST558 could potentially disseminate 
resistance determinants obtained from S. mitis to other 
pneumococcal lineages. Non- typeable pneumococci, 
strains that do not express the pneumococcal capsule, 
were also recipients of pbp fragments, and previously 
pneumococcal recombination studies have highlighted 
these pneumococci as dominant recombination donors 
and recipients [30]. Thus non- typeable pneumococci could 
also potentially disseminate pbp fragments obtained from 
S. mitis to other pneumococcal lineages [100]. We observed 
a high proportion of penicillin resistant ST63 (Serotype 
14/15A) PMEN25 strains from multiple geographical loca-
tions that acquired pbp fragments from predominantly S. 
mitis through HGT. Genetic promiscuity is known to have 
contributed to other highly successful resistant clones, such 
as the PMEN1, which has evaded vaccine pressure multiple 
times and acquired drug resistance [12, 101, 102]. Previous 
comparative analyses of pbp2x genes have indicated that 
mosaic genes of PMEN1 have been observed among global 
viridans species [94]. Therefore, S. mitis may have played 
an important role in the evolution of MDR PMEN line-
ages, such as the PMEN25 clone, and S. mitis may continue 
to facilitate the emergence of β-lactam resistance among 
pneumococcal clones.
Our findings were limited by the number of publicly 
available S. mitis and S. oralis genomes used for the HGT 
analysis, which may have resulted in an underestimation 
of the extent of HGT with the pneumococcus. The under 
sampled non- pneumococcal datasets also do not provide a 
robust statistical signal to fully assess whether one species 
acts as more of a HGT partner compared with another 
and to assess the extent of recent HGT among S. mitis 
and S. oralis. The S. mitis and S. oralis genomes were also 
not all sampled from the same region. Although further 
sequencing of systematically collected commensal strepto-
cocci is warranted, our analysis offers a substantial insight 
into the genetic interactions between the streptococci with 
the publicly available genomic data. We did not include 
other distantly related species of the genus Streptococcus, 
such as Streptococcus infantis, in the analysis due to limited 
publicly available genomic data, but recent data has indi-
cated that S. infantis shares similar capsular genes with the 
pneumococcus [103]. Therefore, it is possible that S. infantis 
may be an important pneumococcal HGT partner involving 
other genes.
Although the in silico HGT analysis could potentially 
introduce artefacts, we investigated HGT at the conserved 
MLST genes and we confirmed minimal exchange among 
the loci. We also investigated HGT among non- pbp AMR 
genes and similarly identified folate biosynthesis genes 
as recombination hotspots as described in earlier work 
[13, 30], thus providing further support for the extensive 
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pbp HGT observations in our analysis. Although we estab-
lished specific dominant GPSC genotypes with a greater 
degree of HGT than other GPSCs, we confirmed that HGT 
also occurs among intermediate and rare GPSC strains.
In conclusion, this large- scale genomic analysis demon-
strates S. mitis to be an important donor and reservoir of pbp 
diversity that was associated with reduced β-lactam suscep-
tibility in carried pneumococci. Expanding pneumococcal 
lineages with increased opportunities for recombination 
through prolonged carriage were among the recipients of 
pbp fragments from S. mitis with the potential to dissemi-
nate resistance determinants to the wider pneumococcal 
population. Investigating the mechanisms of genetic 
transfer through genomic surveillance of the pneumo-
coccus and closely related commensal species is necessary in 
understanding the evolution of β-lactam resistance among 
pneumococcal lineages that escape clinical interventions. 
As pneumococcal vaccine programmes mature, probably 
shifting the pneumococcal population structure, it will be 
important to monitor the influence of HGT of antimicrobial 
resistance determinants from commensal streptococci such 
as S. mitis.
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